We found that most DEGs were enriched in cancer pathways (ko05200), including breast cancer (ko05224), gastric cancer (ko05226) and hepatocellular carcinoma (ko05225), and that some DEGs were also enriched in Wnt (ko04310), mTOR (ko04150) signaling pathways and pathways in regulating pluripotency of stem cells (ko04550). The gene discussed is MTOR; the disease is breast cancer.